These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16121689)

  • 1. Therapy and prophylaxis of Ebola virus infections.
    Feldmann H; Jones SM; Schnittler HJ; Geisbert T
    Curr Opin Investig Drugs; 2005 Aug; 6(8):823-30. PubMed ID: 16121689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a vaccine against Ebola virus.
    Geisbert TW; Jahrling PB
    Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus: from discovery to vaccine.
    Feldmann H; Jones S; Klenk HD; Schnittler HJ
    Nat Rev Immunol; 2003 Aug; 3(8):677-85. PubMed ID: 12974482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995.
    Kerstiëns B; Matthys F
    J Infect Dis; 1999 Feb; 179 Suppl 1():S263-7. PubMed ID: 9988193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
    Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
    Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ebola fever: an emerging disease].
    Jezek Z
    Epidemiol Mikrobiol Imunol; 2001 Apr; 50(2):54-66. PubMed ID: 11329728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ebola virus and yellow fever: lessons to learn from the epidemics].
    Baudon D
    Med Trop (Mars); 1995; 55(2):133-4. PubMed ID: 7564992
    [No Abstract]   [Full Text] [Related]  

  • 11. A DNA vaccine for the prevention of Ebola virus infection.
    Dery M; Bausch DG
    Curr Opin Mol Ther; 2008 Jun; 10(3):285-93. PubMed ID: 18535936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious disease (Ebola virus).
    Murphy L; Newcomb R
    Ky Nurse; 2003; 51(1):12. PubMed ID: 12655811
    [No Abstract]   [Full Text] [Related]  

  • 13. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure.
    Roels TH; Bloom AS; Buffington J; Muhungu GL; Mac Kenzie WR; Khan AS; Ndambi R; Noah DL; Rolka HR; Peters CJ; Ksiazek TG
    J Infect Dis; 1999 Feb; 179 Suppl 1():S92-7. PubMed ID: 9988170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
    Geisbert TW; Hensley LE
    Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1995 Kikwit Ebola outbreak--model of virus properties on system capacity and function: a lesson for future viral epidemics.
    Hall RC; Hall RC
    Am J Disaster Med; 2007; 2(5):270-6. PubMed ID: 18491842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection.
    Lucht A; Formenty P; Feldmann H; Gotz M; Leroy E; Bataboukila P; Grolla A; Feldmann F; Wittmann T; Campbell P; Atsangandoko C; Boumandoki P; Finke EJ; Miethe P; Becker S; Grunow R
    J Infect Dis; 2007 Nov; 196 Suppl 2():S184-92. PubMed ID: 17940948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola hemorrhagic fever: lessons from Kikwit, Democratic Republic of the Congo.
    Heymann DL; Barakamfitiye D; Szczeniowski M; Muyembe-Tamfum JJ; Bele O; Rodier G
    J Infect Dis; 1999 Feb; 179 Suppl 1():S283-6. PubMed ID: 9988197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola hemorrhagic fever in the era of bioterrorism.
    Polesky A; Bhatia G
    Semin Respir Infect; 2003 Sep; 18(3):206-15. PubMed ID: 14505282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever.
    Lloyd ES; Zaki SR; Rollin PE; Tshioko K; Bwaka MA; Ksiazek TG; Calain P; Shieh WJ; Kondé MK; Verchueren E; Perry HN; Manguindula L; Kabwau J; Ndambi R; Peters CJ
    J Infect Dis; 1999 Feb; 179 Suppl 1():S274-80. PubMed ID: 9988195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filovirus research: knowledge expands to meet a growing threat.
    Bray M; Murphy FA
    J Infect Dis; 2007 Nov; 196 Suppl 2():S438-43. PubMed ID: 17940981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.